Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Pilot Study of Reduced Fluence Photodynamic Therapy With Visudyne® (Verteporfin) in Combination With Lucentis™ (Ranibizumab) for the Treatment of Age-Related Macular Degeneration

NCT00473642 is registered in ClinicalTrials.gov with Oklahoma State University Center for Health Sciences as lead sponsor.

NCT NCT00473642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00473642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Pilot Study of Reduced Fluence Photodynamic Therapy With Visudyne® (Verteporfin) in Combination With Lucentis™ (Ranibizumab) for the Treatment of Age-Related Macular Degeneration
Lead sponsor
Oklahoma State University Center for Health Sciences
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2007
Completion date
April 30, 2010
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related maculopathy, choroidal neovascularization